期刊文献+

全身麻醉药在蛋白模型和离子通道的分子靶位及变构调节机制 被引量:3

The allosteric regulation of general anesthetics on protein models and ion channels as well as their target sites
原文传递
导出
摘要 背景全麻药地氟醚和丙泊酚与原核细胞膜中的五聚体配体门控型离子通道(pentameric ligand-gated ion channels,pLGICs)复合体的结晶结构,为研究全麻药与大脑pLGICs变构调节部位之间的相互作用提供了一个新奇的结构框架,使全麻药作用机制的变构调节学说有了许多新的实验支持。目的概述全麻药作用的分子靶位及变构调节机制。内容简介“变构”(“allosteric”)一词的由来及发展,阐述麻醉药在蛋白模型和离子通道的分子靶位及调节机制,提出麻醉药在pLGICs的分子靶位有两个关键结合位点,分别通过影响受体的亲和力或直接对受体发挥作用,而影响受体亲和力的主要分子机制是变构调节。趋势随着科技的发展及许多新技术和新方法的应用,全麻药在中枢神经系统的各种分子靶位及调节机制将逐步得到破解。 Background The complex crystal structure of general anesthetics desflurane or propofol and pentameric ligandgated ion channels (pLGICs) in prokaryotic cell membrane, provides a novel structural framework for the design of general anesthetics and of allosteric modulators of brain pLGICs and gets many new experiment support about the allosteric regulation theory. Objective To summarize the general anesthetics molecular sites and allosteric regulation mechanism. Content This paper introduces the origin and development of the word "al]osteric", expounds the molecular sites and modulate mechanisms of general anesthetics action on protein models and ion channels, and proposes two key binding sites of anesthetics in pLGICs mediating receptor affinity and direct activation receptor respectively. But the allosteric regulation is the main mechanism of mediating receptor affinity. Trend With the development of science and technology and application of many new technology and new method, it will gradually be understanded that various kinds of molecular sites of general anesthetics in the central nervous system and regulation mechanism.
出处 《国际麻醉学与复苏杂志》 CAS 2014年第1期72-74,82,共4页 International Journal of Anesthesiology and Resuscitation
关键词 全麻药 蛋白模型 离子通道 分子机制 变构调节 General anesthetics Protein model Ion channels Molecular mechanism Allosteric regulation
  • 相关文献

参考文献19

  • 1Hemmings HC, Akabas MH, Goldstein PA, et al. Emerging molecular mechanisms of general anesthetic action[J]. Trends Pharmacol Sci, 2005, 26(10): 503-510.
  • 2Liu R, Loll PJ, Eckenhoff RG. Structural basis for high-affinity volatile anesthetic binding in a natural 4-helix bundle protein[J]. FASEB J, 2005, 19(6): 567-576.
  • 3Vedula LS, Brannigan G, Economou NJ, et al. A unitary anesthetic binding site at high resolution[J]. J Biol Chem, 2009, 284(36 ) : 24176-24184.
  • 4Nury H, Van Renterghem C, Weng Y, et al. X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel [J]. Nature, 2011, 469(7330): 428-431.
  • 5Guitehounts G, Stewart DS, Forman SA.Two etomidate sites in ct1132")'2 /-aminobutyrie acid type a receptors contribute equally and noneooperatively to modulation of channel gating [ J ]. Anesthesiology, 2012, 116( 6 ) : 1235 -1244.
  • 6Ruesch D, Neumann E, Wulf H, et al. An allosterie eoagonist model for propofol effects on ctl132",/2L /-aminobutyric acid type A receptors[J ]. Anesthesiology, 2012, 116( 1 ) : 47-55.
  • 7Monod J, Wyman J, Changeux JP. On the nature of allosteric transitions: a plausible model[J]. J Mol Biol, 1965, 12(1 ) : 88-118.
  • 8Changeux JP. 50th anniversary of the word "Allosteric"[ J ]. Protein Sei, 2011, 20(7): 1119-1124.
  • 9Yuki K, Astrof NS, Bracken C, et al. The volatile anestheticisoflurane perturbs conformational activa|ion of integrin LFA-1 by binding to the allosterie regulatory cavity[J]. FASEB J, 2008, 22 (12): 4109-4116.
  • 10江山,何绍明.挥发性全麻药作用机制的变构理论[J].国际麻醉学与复苏杂志,2012,33(8):554-557. 被引量:2

二级参考文献20

  • 1McBride WT, Armstrong MA, McBride SJ. Immunomodulation: an important concept in modem anaesthesia. Anaesthesia, 1996, 51 (5): 465-473.
  • 2Yuki K, Astrof NS, Bracken C, et al. The volatile anesthetic isoflurane perturbs conformational activation of integrin LFA-1 by binding to the allosteric regulatory cavity. FASEB J, 2008, 22 (12): 4109-4116.
  • 3Eckenhoff RG, Pidikiti R, Reddy KS. Anesthetic stabilization of protein intermediates: myoglobin and halothane. Biochemistry, 2001, 40(36): 10819-10824.
  • 4Liu R, Loll PJ, Eckenhoff RG. Structural basis for high-affinity volatile anesthetic binding in a r-atural 4-helix bundle protein. FASEB J, 2005, 19(6): 567-576.
  • 5Shimaoka M, Springer TA. Therapeutic antagonists and the conformational regulation of integrin structure and function. Nat Rev Drug Disc, 2003, 2(9): 703-716.
  • 6Zhang H, Astrof NS, Liu JH, et al. Crystal structure of isoflurane bound to integrin LFA-1 supports a unified mechanism of volatile anesthetic action in the immune and central nervous systems. FASEB J, 2009, 23(8): 2735-2740.
  • 7Eger EI 2nd, Koblin DD, Harris RA, et al. Hypothesis: inhaled anesthetics produce immobility and amnesia by different mechanisms at different sites. Anesth Analg, 1997, 84 (4): 915- 918.
  • 8Grasshoff C, Rudolph U, Antkowiak B. Molecular and systemic mechanisms of general anaesthesia: the'multi-site and multiple mechanisms'concept. Curr Opin Anaesthesiol, 2005, 18(4): 386- 391.
  • 9Dilger JP. The effects of general anaesthetics on ligand-gated ion channels. Br J Anaesth, 2002, 89(1) : 41-51.
  • 10Urban BW. The site of anesthetic action. Handb Exp Pharmacol, 2008, 182: 3-29.

共引文献1

同被引文献32

  • 1何绍明.吸入麻醉药作用机制的5埃理论[J].国际麻醉学与复苏杂志,2007,28(1):41-43. 被引量:2
  • 2Belelli D, Harrison NL, Maguire J, et al. Extrasynaptic GABAareceptors: form, pharmacology, and function [J]. J Neurosci,2009, 29(41): 12757-12763.
  • 3Garcia PS, Kolesky SE, Jenkins A. General anesthetic actions onGABAa receptors[J]. Curr Neuropharmacol, 2010, 8( ] ): 2-9.
  • 4Farrant M, Nusser Z. Variations on an inhibitory theme : phasic andtonic activation of GABAa receptors[J], Nat Rev Neurosci, 2005, 6(3): 215-229.
  • 5Campagna JA, Miller KW,Forman SA. Mechanisms of actionsof inhaled anesthetics[J]. N Engl J Med, 2003, 348(21) : 2110-2124.
  • 6McCartney MR, Deeb TZ, Henderson TN, et al. Tonically activeGABAA receptors in hippocampal pyramidal neurons exhibitconstitutive GABA-independent gating [J]. Mol Pharmacol, 2007,71(2): 539-548.
  • 7Son Y. Molecular mechanisms of general anesthesia [J]. Korean JAnesthesiol, 2010, 59(1): 3-8.
  • 8Thompson AJ, Alqazzaz M, Ulens C,et al. The pharmacologicalprofile of ELIC, a prokaryotic GABA -^ated receptor [J].Neuropharmacology, 2012,63(4): 761-767.
  • 9Nutt DJ, Besson M, Wilson SJ, et al. Blockade of alcohol's amnesticactivity in humans by an alpha5 subtype benzodiazepine receptorinverse agonist[J]. Neuropharmacology, 2007, 53(7) : 810-820.
  • 10Herd MB, Lambert JJ, Belelli D. The general anaesthetic etomidateinhibits the excitability of mouse thalamocortical relay neurons bymodulating multiple modes of GABAa receptor -mediated inhibition[J]. Eur J Neurosci, 2014,40(3): 2487-2501.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部